Pharm
Acetazolamide
search
Acetazolamide
, Diamox, Systemic Carbonic Anhydrase Inhibitor
See Also
Intraocular Carbonic Anhydrase Inhibitor
Indications
High Altitude Sickness
treatment and prevention
Pseudotumor Cerebri
Glaucoma
Intraocular Carbonic Anhydrase Inhibitor
Open Angle Glaucoma
Systemic Acetazolamide (IV or oral) Indications
Acute angle closure
Glaucoma
before surgery
Acute exacerbation of chronic
Open Angle Glaucoma
Other indications
Periodic Paralysis
Marfan Syndrome
related dural ectasia
Stable Hypercapnic
Respiratory Failure
(respiratory stimulant)
Epilepsy
FDA approved for
Seizure
s since 1956
Has been used for Catamenial
Epilepsy
, Myoclonic, Absence and
Generalized Seizure
s
Reiss (1996) Ann Pharmacother 30(5):514-9 [PubMed]
Contraindications
Sulfonamide Allergy
or
Anaphylaxis
Stevens-Johnson Syndrome
or
Toxic Epidermal Necrolysis
history
Hyponatremia
Hypokalemia
Hyperchloremic Metabolic Acidosis
Adrenal Insufficiency
Cirrhosis
or other severe liver disease
Severe renal disease
Mechanism
Diuretic
in the Carbonic Anhydrase Inhibitor Class
Decreases secretion of
Aqueous Humor
(
Glaucoma
)
Decreases
Hydrogen Ion
at renal proximal tubule
Prevents renal bicarbonate reuptake resulting in urine alkalization (and blood acidification)
Increased renal excretion of
Sodium
,
Potassium
, bicarbonate and water
Results in hypokalemic
Metabolic Acidosis
and
Respiratory Alkalosis
(mechanism in
High Altitude Illness
)
Lower resting
PaCO2
Higher resting
Minute Ventilation
Increased
PaO2
Dosing
High Altitude Sickness
Prevention
Adults: 125 mg orally every 12 hours (FDA approved)
Up to 250 mg twice daily may be used (but 125 mg is typically sufficient)
Doses of 1000 mg/day (with added
Dexamethasone
) have been used for rapid ascent (e.g. rescue)
Children: 2.5 mg/kg up to 125 mg every 12 hours (off-label)
Start 24 hours before ascent
Continue for 72 hours or until acclimitization to highest sleeping altitude
Insomnia
at altitude: 125 mg orally at bedtime
Treatment: Adults
Start: 250 mg orally twice daily
Range: 500 to 1000 mg/day divided every 8 to 12 hours (every 12 to 24 hours if extended release)
Often used in combination with
Dexamethasone
Pseudotumor Cerebri
Dose range: 125-250 mg orally daily to three times daily
Open Angle Glaucoma
acute exacerbation or Acute
Narrow Angle Glaucoma
prior to surgery
Dose: 250 mg orally or IV every 4-6 hours (maximum 1 gram/day)
Adverse Effects
Common
Hypokalemia
Hyponatremia
Metabolic Acidosis
Peripheral
Paresthesia
s (common)
Polyuria
Taste Dysfunction
(
Dysgeusia
) with bitter or
Metallic Taste
Headache
Nausea
or
Vomiting
Abdominal Cramping
Black
Stool
Diarrhea
Fatigue
Drowsiness
Depressed Mood
Decreased Libido
Ureteral Stone
s
Adverse Effects
Uncommon Serious
Stevens-Johnson Syndrome
Anaphylaxis
Blood Dyscrasias
Drug Interactions
Cyclosporine
Salicylate
s
Safety
Pregnancy Category C
Safe in
Lactation
Resources
Acetazolamide Tablets (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0913db35-3f08-4d82-8394-486bd9a487c4
References
Olson (2020) Clinical
Pharmacology
, Medmaster, Miami, p. 62-3
Hamilton (2010) Tarason Pocket Pharmacopeia, p. 224
Lovecchio (2017) Crit Dec Emerg Med 31(8): 28
Lovecchio (2022) Crit Dec Emerg Med 36(3): 28
Type your search phrase here